MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517039607 A) filed by Shanghai Apeiron Therapeutics Company Limited, Shanghai, on April 24, for 'novel prmt5 inhibitor and use thereof.'
Inventor(s) include Yao, Bing; and Gu, Xiaohui.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "The present invention describes a novel molecule with inhibitory activity against protein arginine methyltransferase and methods for synthesis and use of the compound. Specifically, the present invention describes a compound of formula (I) or a pharmaceutically acceptable salt thereof, a hydrate therof, or a solvate thereof, and methods for synthesis and use of the compound."
The patent application was internationally filed on Sept. 25, 2023, under International application No.PCT/CN2023/120923.
Disclaimer: Curated by HT Syndication.
